Riskpilot← Back to searchSign inGet full accessBioNordika Oy
OYActiveY-tunnus 1058730-0Kutomotie 18Wholesale of pharmaceutical and medical goods · NACE 4646Est. 19959 employeeswww.bionordika.fi
Revenue 2024
EUR 0
EBITDA margin
—
Equity ratio
28.4%
Financial strength
Net profit 2024
EUR 0
9 employees
| Revenue | EUR 0 | — |
| EBITDA | EUR 0 | — |
| Net profit | EUR 0 | — |
| Total assets | EUR 540K | +17% |
| Equity | EUR 153K | -38% |
| Employees | 9 | — |
Legal name
BioNordika Oy
Y-tunnus number
1058730-0
Legal form
Osakeyhtiö
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
22. marraskuuta 1995
Share capital
EUR 100 913
Employees
9 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Bolaget har till föremål för sin verksamhet att idka handel med och tillverka instrument, apparater och komponenter inom industriell process-styrning, dental, medicinsk och kemisk bransch, ävensom driva annan därmed förenlig verksamhet.
Address
Kutomotie 18
Phone
+3580207410270
Email
info@bionordika.fi
Website
www.bionordika.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 970 | 3 174 | 3 610 | — | 0 |
| Staff expenses | −564 | −641 | −689 | — | −0 |
| EBITDA | 446 | 432 | 465 | — | 0 |
| Depreciation & amort. | −14 | −14 | −9 | — | −0 |
| EBIT | 432 | 418 | 456 | — | 0 |
| Net financials | −4 | −4 | −2 | — | 0 |
| Profit before tax | 428 | 421 | 454 | — | 0 |
| Tax | 86 | 83 | 91 | — | −0 |
| Net profit | 342 | 339 | 363 | — | 0 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 110 | 1 167 | 1 511 | 461 | 540 |
| Equity | 564 | 582 | 615 | 246 | 153 |
| Long-term debt | 68 | 60 | 39 | 0 | 0 |
| Short-term debt | 479 | 524 | 857 | 964 | 540 |
| Total debt | 547 | 584 | 896 | 0 | 0 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20202024
Equity ratio
28.4%
This company
38.2%
Market median
-26% vs market
20202024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20202024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
2.52×
This company
0.62×
Market median
-306% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
RM Person with significant control | Person with significant control | 2023 |
SE Chief Executive Officer | Chief Executive Officer | 2019 |
| Former (3) | ||
TA Person with significant control | Person with significant control | 2015 – 2019 |
TH | Audit | 2006 – 2021 |
TM Audit | Audit | 2021 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2024 | |
| Chairperson | 2025 | |
| Board of Directors | 2018 | |
| Board of Directors | 2024 | |
| Former (1) | ||
| Board of Directors | 2018 – 2019 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BioNordika Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rolf Mattias Bengtsson | Person with significant control | 0 companies |
| Tommi Antero Laatikainen | Person with significant control | 0 companies |
| Tom Hans Henrik Kullberg | Audit | 0 companies |
| Toni Mikael Ramu | Audit | 0 companies |
| Sari Eija Birgitta Nousiainen | Chief Executive Officer | 0 companies |
| Peter Mikael Simonsbacka | Board of Directors | 0 companies |
| Heinrich Preben Biehl | Board of Directors | 0 companies |
| Jussi Sakari Kurittu | Chairperson | 0 companies |
| Haakon Rivertz Torgersen | Board of Directors | 0 companies |
| Michael Hartmann | Board of Directors | 0 companies |